The Blue Jays have launched its own probe following the scandal that rocked its minor league team after six of its players in the Dominican Summer League were slapped suspensions for violating the MLB’s anti-doping policy.
In a statement, Blue Jays general manager Ross Atkins said that they are obviously disappointed that the players chose to disregard the rule against the use of performance-enhancing substances. But they are more disappointed that they failed to prevent it from happening in the first place.
He said the Blue Jays have the responsibility to ingrain in the players that the use of PED is not going to be allowed. The team also has the burden of providing “resources and education” to the players so they don’t make the wrong decisions.
“As we seek to determine both how and why this happened, an internal investigation into the situation remains ongoing,” he said. “We will double down on ensuring that all our staff is properly equipped to help our players make the right choices.”
The six players tested positive for the anabolic steroid boldenone, which is better known as Equipoise, which was originally used for horses. They were identified as pitchers Jol Concepcion, Juan Jimenez and Naswell Paulino; catcher Leonicio Ventura, shortstop Hugo Cardona, and left fielder Yhon Perez.
Bleacher Report said that Concepcion was suspended for 60 games while the rest received harsher punishments, or for 72 games.
The latest scandal shows a gaping hole in the screening system of the Blue Jays.
In fact, according to Sportsnet.ca, the Blue Jays accounted for nine percent of the total 79 doping-related suspensions in the minor league this year. The team investigators will likely trace the distribution source if all of its suspended players were sharing the same drug. However, the team didn’t want to reveal details of their investigation.